(Q83393091)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21307882%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

title

Common matrix metalloproteinase 2 gene haplotypes may modulate left ventricular remodelling in hypertensive patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21307882%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author

Marcelo Rizzatti Luizon

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21307882%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

R Lacchini

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21307882%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

A L B Jacob-Ferreira

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21307882%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

S Gasparini

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21307882%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

M C S Ferreira-Sae

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21307882%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

R Schreiber

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21307882%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

W Nadruz

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21307882%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

J E Tanus-Santos

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21307882%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

publication date

10 February 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21307882%20AND%20SRC:MED&resulttype=core&format=json

Journal of Human Hypertension

22 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21307882%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21307882%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21307882%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

page(s)

171-177

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21307882%20AND%20SRC:MED&resulttype=core&format=json

Cardiac hypertrophy: the good, the bad, and the ugly

22 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.8

7 January 2021

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.8

7 January 2021

Regulation of matrix metalloproteinases and their inhibitors in the left ventricular myocardium of patients with aortic stenosis.

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.8

7 January 2021

MMP-2/TIMP-2/TIMP-4 versus MMP-9/TIMP-3 in transition from compensatory hypertrophy and angiogenesis to decompensatory heart failure.

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.8

7 January 2021

Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.8

7 January 2021

The dynamic interaction between matrix metalloproteinase activity and adverse myocardial remodeling

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.8

7 January 2021

Matrix metalloproteinases and their tissue inhibitors in pressure-overloaded human myocardium during heart failure progression

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.8

7 January 2021

Matrix Metalloproteinase Inhibition Improves Cardiac Dysfunction and Remodeling in 2-Kidney, 1-Clip Hypertension

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.8

7 January 2021

Myocardial matrix remodeling and the matrix metalloproteinases: influence on cardiac form and function

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.8

7 January 2021

Variants of the Matrix Metalloproteinase-2 but not the Matrix Metalloproteinase-9 genes significantly influence functional outcome after stroke

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.8

7 January 2021

Matrix metalloproteinase (MMP-9 and MMP-2) gene polymorphisms influence allograft survival in renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.8

7 January 2021

Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.8

7 January 2021

Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.8

7 January 2021

MMP-2 geno-phenotype is prognostic for colorectal cancer survival, whereas MMP-9 is not

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.8

7 January 2021

The role of MMP-2 and MMP-9 polymorphisms in sporadic intracranial aneurysms

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.8

7 January 2021

Prognostic impact of matrix metalloproteinase gene polymorphisms in patients with heart failure according to the aetiology of left ventricular systolic dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.8

7 January 2021

MMP-2 and TIMP-2 gene polymorphisms and susceptibility to atrial fibrillation in Chinese Han patients with hypertensive heart disease

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.8

7 January 2021

A prospective evaluation of left ventricular remodeling after inaugural anterior myocardial infarction as a function of gene polymorphisms in the renin-angiotensin-aldosterone, adrenergic, and metalloproteinase systems

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.8

7 January 2021

Genes Predisposing to Rapid Aneurysm Growth

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.8

7 January 2021

Non-effect of p22-phox −930A/G polymorphism on end-organ damage in Brazilian hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.8

7 January 2021

Recommendations for chamber quantification

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.8

7 January 2021

A new method for indexing left ventricular mass for differences in body size

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.8

7 January 2021

Score tests for association between traits and haplotypes when linkage phase is ambiguous

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.8

7 January 2021

Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.8

7 January 2021

Imbalance between matrix metalloproteinases and tissue inhibitor of metalloproteinases in hypertensive vascular remodeling

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.8

7 January 2021

Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.8

7 January 2021

Lercanidipine reduces matrix metalloproteinase-2 activity and reverses vascular dysfunction in renovascular hypertensive rats

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.8

7 January 2021

Metalloproteinases 2 and 9 are increased in plasma of patients with heart failure

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.8

7 January 2021

Matrix metalloproteinase-2 and myocardial oxidative stress injury: beyond the matrix

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.8

7 January 2021

Targeted deletion of matrix metalloproteinase 2 ameliorates myocardial remodeling in mice with chronic pressure overload.

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.8

7 January 2021

Progress in matrix metalloproteinase research

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.8

7 January 2021

Matrix metalloproteinase 9 gene haplotypes affect left ventricular hypertrophy in hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.8

7 January 2021

Matrix metalloproteinases and tissue remodeling in hypertrophic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.8

7 January 2021

Intracellular targets of matrix metalloproteinase-2 in cardiac disease: rationale and therapeutic approaches

1 reference

https://api.crossref.org/works/10.1038%2FJHH.2011.8

7 January 2021